Theodore Lawrence

With his medical degree, Lawrence then completed his residency in internal medicine at Stanford University and National Cancer Institute.

[3] During his early tenure at the institution, he developed combined treatments of intensified chemotherapy and radiation for patients with pancreatic cancer.

[5] In 2007, Larence was recognized for his scientific achievements with an election to the National Academy of Medicine.

[4] A few years later, he was the recipient of the 2009 Gold Medal from the American Society for Radiation Oncology.

[6] In 2015, Lawrence was appointed the director of the University of Michigan Rogel Cancer Center.